The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
High 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer
Abstract
OBJECTIVE: To learn about the natural history of untreated, early-stage prostatic cancer. DESIGN: Cohort study with a mean follow-up of 123 months (range, 81 to 165 months). SETTING: Population-based, regionally well defined. PATIENTS: A consecutive sample of 223 patients (98% of all eligible) with early-stage (T0-2, NX, M0), initially untreated prostatic cancer. MAIN OUTCOME MEASURES: Progression-free, disease-specific, and overall survival. Need for palliative and terminal care. INTERVENTION: Patients with tumor progression were hormonally treated (orchiectomy or estrogens) if they had symptoms. RESULTS: After complete follow-up, only 19 (8.5%) of the 223 patients had died of prostate cancer and 105 (85%) of a total of 124 deaths were from other causes. The 10-year, disease-specific survival rate was 86.8% (95% confidence interval, 80.7% to 92.9%) and was equally high (87.9%) in a subgroup of 58 patients who met current indications for radical prostatectomy. The progression-free, 10-year survival rate was 53.1% (95% confidence interval, 44.2% to 62.0%). In 50 of 76 patients, local growth provided the only evidence of progression, and endocrine treatment was generally successful in these cases. Following an initial increase, the rate of disease progression and death from prostate cancer decreased during the last years of follow-up. CONCLUSION: The low disease-specific mortality rate, especially in patients with highly and moderately differentiated tumors, means that any local or systemic therapy intended for patients with early prostatic cancer must be evaluated in clinical trials with untreated controls for comparison.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Maximum utilization of the life table method in analyzing survival
Cutler, S. J., & Ederer, F. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90126-7 · Cited by 2,870
The relative survival rate: a statistical methodology.
Ederer, F., Axtell, L. M., & CUTLER, S. J. (1961) · PubMed · Cited by 1,169
Early Detection of Prostate Cancer
Scardino, P. T. (1989) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)01800-0 · Cited by 209
On long-term relative survival rates
Hakulinen, T. R. (1977) · Journal of Chronic Diseases · doi:10.1016/0021-9681(77)90036-4 · Cited by 153
Total Prostatectomy for Clinically Localized Prostatic Cancer: Long-term Results
Gibbons, R. P., Correa, R. J., Brannen, G. E., & Weissman, R. M. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)40895-0 · Cited by 145
Chemotherapy of advanced prostatic cancer Evaluation of response parameters
Schmidt, J. D., Johnson, D. E., Scott, W. W., Gibbons, R. P., Prout, G. R., & Murphy, G. P. (1976) · Urology · doi:10.1016/0090-4295(76)90085-6 · Cited by 130
Cited by
Burke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Self-citationThe Role of Increasing Detection in the Rising Incidence of Prostate Cancer
Potosky, A. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520310046028 · Cited by 674
Zincke, H., Oesterling, J. E., Blute, M. L., Bergstralh, E. J., Myers, R. P., & Barrett, D. M. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32399-6 · Cited by 672
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
Demichelis, F., Fall, K., Perner, S., Andrén, O., Schmidt, F., Setlur, S. R., Hoshida, Y., Mosquera, J.-M., Pawitan, Y., Lee, C., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210237 · Cited by 645
Self-citation
Metadata
- Authors
- Johansson, J.-E.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1992-04-22
- Volume
- 267
- Issue
- 16
- Pages
- 2191
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2064028125
- Cited by
- 467
- References
- 8
- FWCI
- 78.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer. https://app.cochat.ai/papers/10.1001/jama.1992.03480160049033
- The paper
- Johansson, J.-E. (1992). High 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer. JAMA: The Journal of the American Medical Association. https://doi.org/10.1001/jama.1992.03480160049033
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.